✦ LIBER ✦

Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer: combined analysis of the Japan Clinical Oncology Group Trials JCOG9205 and JCOG9912

✍ Scribed by Takashima, Atsuo; Boku, Narikazu; Kato, Ken; Nakamura, Kenichi; Mizusawa, Junki; Fukuda, Haruhiko; Shirao, Kuniaki; Shimada, Yasuhiro; Ohtsu, Atsushi

Book ID: 121611507
Publisher: Springer
Year: 2013
Tongue: English
Weight: 375 KB
Volume: 17
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-013-0309-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of excision repair cross-compleme

Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912

✍ Yamada, Y.; Boku, N.; Nishina, T.; Yamaguchi, K.; Denda, T.; Tsuji, A.; Hamamoto 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 160 KB

A phase II study of biweekly mitomycin C

A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)

✍ Tetsuya Hamaguchi; Kuniaki Shirao; Atsushi Ohtsu; Ichinosuke Hyodo; Yasuaki Arai 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 341 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB